Tarsons Products Limited (TARSONS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.071x

Based on the latest financial reports, Tarsons Products Limited (TARSONS) has a cash flow conversion efficiency ratio of 0.071x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs444.51 Million ≈ $4.81 Million USD) by net assets (Rs6.27 Billion ≈ $67.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see TARSONS stock market capitalisation for the company's overall valuation and market capitalisation.

Tarsons Products Limited - Cash Flow Conversion Efficiency Trend (2019–2026)

This chart illustrates how Tarsons Products Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tarsons Products Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tarsons Products Limited ranked by their cash flow conversion efficiency. Explore Tarsons Products Limited earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Indeks Bilgisayar Sistemleri Muhendislik Sanayi ve Ticaret AS
IS:INDES
0.147x
BAPCOR LTD.
F:0BS
N/A
Crown Reserve Acquisition Corp. I Class A Ordinary Shares
NASDAQ:CRAC
0.000x
Melar Acquisition Corp. I Class A Ordinary Shares
NASDAQ:MACI
-0.001x
RADCOM Ltd
F:RAM
N/A
Canton Strategic Holdings, Inc.
NASDAQ:CNTN
-0.005x
Caisse Regionale de Credit Agricole Mutuel du Languedoc
PA:CRLA
0.051x
Jaeren Sparebank
OL:JAREN
-0.105x

Annual Cash Flow Conversion Efficiency for Tarsons Products Limited (2019–2026)

The table below shows the annual cash flow conversion efficiency of Tarsons Products Limited from 2019 to 2026. View today's stock price for Tarsons Products Limited for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs6.35 Billion
≈ $68.63 Million
Rs1.18 Billion
≈ $12.81 Million
0.187x +21.78%
2025-03-31 Rs6.30 Billion
≈ $68.15 Million
Rs966.20 Million
≈ $10.45 Million
0.153x -8.51%
2024-03-31 Rs6.13 Billion
≈ $66.28 Million
Rs1.03 Billion
≈ $11.11 Million
0.168x +26.20%
2023-03-31 Rs5.69 Billion
≈ $61.57 Million
Rs755.99 Million
≈ $8.18 Million
0.133x -22.07%
2022-03-31 Rs4.90 Billion
≈ $52.97 Million
Rs834.67 Million
≈ $9.03 Million
0.170x -38.91%
2021-03-31 Rs2.44 Billion
≈ $26.42 Million
Rs681.55 Million
≈ $7.37 Million
0.279x -14.18%
2020-03-31 Rs1.98 Billion
≈ $21.37 Million
Rs642.16 Million
≈ $6.94 Million
0.325x -14.36%
2019-03-31 Rs1.35 Billion
≈ $14.63 Million
Rs513.41 Million
≈ $5.55 Million
0.380x --

About Tarsons Products Limited

NSE:TARSONS India Medical Instruments & Supplies
Market Cap
$176.13 Million
Rs16.29 Billion INR
Market Cap Rank
#17132 Global
#901 in India
Share Price
Rs306.10
Change (1 day)
-0.55%
52-Week Range
Rs166.46 - Rs361.50
All Time High
Rs867.38
About

Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers assay plates, biohazard and safetyware, bioprocessing solutions, bottles and carboys, boxes and racks, cell culture ware, centrifuge ware, clamps and stands, clinical and microbiology products, cryoware, desiccators, tubings and connectors, filtration products, … Read more